Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The respiratory tract secretions/mucus production pathway is a complex process crucial for airway defense. It involves coordinated secretion of mucins and other components by goblet cells, club cells, and submucosal glands. MUC5AC and MUC5B are the major mucins. Regulation occurs via ATP/P2Y₂ receptor signaling, cholinergic agonists, and inflammatory mediators. Dysregulation leads to mucus hypersecretion and contributes to diseases like asthma, COPD, and cystic fibrosis. Therapeutic strategies aim to modulate mucus production, viscosity, and clearance to restore airway homeostasis.
Modulation of mucus production, viscosity, and clearance; reduction of inflammation; restoration of CFTR function.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Respiratory Tract Secretions/Mucus Production Pathway (None).